These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14657950)

  • 1. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer.
    Saad RS; Liu YL; Nathan G; Celebrezze J; Medich D; Silverman JF
    Mod Pathol; 2004 Feb; 17(2):197-203. PubMed ID: 14657950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoglin (CD105) expression in endometrial carcinoma.
    Saad RS; Jasnosz KM; Tung MY; Silverman JF
    Int J Gynecol Pathol; 2003 Jul; 22(3):248-53. PubMed ID: 12819391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma.
    Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF
    Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic microvessel density as prognostic marker in colorectal cancer.
    Saad RS; Kordunsky L; Liu YL; Denning KL; Kandil HA; Silverman JF
    Mod Pathol; 2006 Oct; 19(10):1317-23. PubMed ID: 16799477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
    El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS
    Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
    Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
    Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
    Behrem S; Zarkovic K; Eskinja N; Jonjic N
    Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
    Yao Y; Kubota T; Takeuchi H; Sato K
    Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
    Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.
    Wikström P; Lissbrant IF; Stattin P; Egevad L; Bergh A
    Prostate; 2002 Jun; 51(4):268-75. PubMed ID: 11987155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
    Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
    Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoglin expression as a measure of microvessel density in cervical cancer.
    Brewer CA; Setterdahl JJ; Li MJ; Johnston JM; Mann JL; McAsey ME
    Obstet Gynecol; 2000 Aug; 96(2):224-8. PubMed ID: 10908767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The angiogenesis in colorectal carcinomas with and without lymph node metastases.
    Gurzu S; Jung J; Azamfirei L; Mezei T; Cîmpean AM; Szentirmay Z
    Rom J Morphol Embryol; 2008; 49(2):149-52. PubMed ID: 18516319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
    Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.
    Minhajat R; Mori D; Yamasaki F; Sugita Y; Satoh T; Tokunaga O
    Virchows Arch; 2006 Feb; 448(2):127-34. PubMed ID: 16177881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
    Randall LM; Monk BJ; Darcy KM; Tian C; Burger RA; Liao SY; Peters WA; Stock RJ; Fruehauf JP
    Gynecol Oncol; 2009 Mar; 112(3):583-9. PubMed ID: 19110305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Endoglin and Vascular Endothelial Growth Factor as Prognostic Markers in Experimental Colorectal Cancer.
    Ilhan N; Gungor H; Gul HF; Eroksuz H
    Anticancer Res; 2016 Aug; 36(8):3953-9. PubMed ID: 27466499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.
    Ho JW; Poon RT; Sun CK; Xue WC; Fan ST
    World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.